Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy
Clinical trial NCT00127569 · TERMINATED
Trial details
- NCT number
- NCT00127569
- Sponsor
- French National Agency for Research on AIDS and Viral Hepatitis
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-05-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.